Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hrishi Varayathu"'
Autor:
Hrishi Varayathu, Mansi Sandip Shah, Vinu Sarathy, Beulah Elsa Thomas, Vinayak Munirathnam, Shivakumar Swamy Shivalingappa, Radheshyam Naik
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1171-1175 (2020)
Ogilvie syndrome or intestinal pseudo-obstruction is a clinical syndrome characterized by autonomic imbalance affecting peristalsis of colon leading to obstructive signs and symptoms. The etiologies commonly implicated are drugs affecting the choline
Externí odkaz:
https://doaj.org/article/0f4dfb78753d4240b2f719178f6c54c0
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immune checkpoint inhibitor therapy has revolutionized the field of cancer immunotherapy. Even though it has shown a durable response in some solid tumors, several patients do not respond to these agents, irrespective of predictive biomarker (PD-L1,
Externí odkaz:
https://doaj.org/article/cc2dafec684e4004bca75282184623d8
Publikováno v:
Advances in Lung Cancer. 10:21-39
With advances in targeted and personalized treatment for lung cancer, molecular analysis of tumors is routinely performed for sequencing of treatment options in patients with advanced non-small-cell lung cancer (NSCLC). Oncogene addiction due to driv
Autor:
Mansi Sandip Shah, Vinayak Munirathnam, Vinu Sarathy, Beulah Elsa Thomas, Shivakumar Swamy Shivalingappa, Radheshyam Naik, Hrishi Varayathu
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 3, Pp 1171-1175 (2020)
Case Reports in Oncology, Vol 13, Iss 3, Pp 1171-1175 (2020)
Ogilvie syndrome or intestinal pseudo-obstruction is a clinical syndrome characterized by autonomic imbalance affecting peristalsis of colon leading to obstructive signs and symptoms. The etiologies commonly implicated are drugs affecting the choline
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Immune checkpoint inhibitor therapy has revolutionized the field of cancer immunotherapy. Even though it has shown a durable response in some solid tumors, several patients do not respond to these agents, irrespective of predictive biomarker (PD-L1,
Autor:
Satheesh Chiradoni Thungappa, Hrishi Varayathu, Radheshyam Naik, Suhail Sayeed Mufti, Lalram Sangi, Vinu Sarathy, Priyank Tripathi, Beulah Elsa Thomas
Publikováno v:
Journal of cancer research and therapeutics. 17(1)
This study is an overall clinical analysis of anti-programmed cell death 1 (PD1) antibodies used in a single institution, emphasizing the role of baseline peripheral blood markers as a prognostic or predictor biomarker of immunotherapy.Sixty-one pati
Publikováno v:
Journal of Oncology, Vol 2021 (2021)
Journal of Oncology
Journal of Oncology
Background. Induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by definitive concurrent chemoradiation remains the standard of care in locally advanced squamous cell carcinoma of head and neck cancers despite which the sur
Autor:
Vinu Sarathy, Vijay Raju Krupesh, Yogendra Shrestha, Gogana Prabhakar Rao, Hrishi Varayathu, Radheshyam Naik
Publikováno v:
Molecular and Clinical Oncology
Hypermagnesemia is often an under reported finding in critically ill patients with cancer. Hypomagnesemia is a commonly encountered electrolyte abnormality in patients with cancer that is primarily caused by a reduced intake, secondary to chemotherap
Autor:
Goutham Kumar, Anju Murugan, Basavalinga S. Ajaikumar, Shalaka Somayaji, Smruthy Ann Mathew, Priyank Tripathi, Suhail Sayeed Mufti, Beulah Elsa Thomas, Radheshyam Naik, Lalram Sangi, Hephzibah Sara Mathew, Hrishi Varayathu, Sunny Kumar Gupta, Sonia Rani
Publikováno v:
Journal of Clinical Oncology. 39:e18802-e18802
e18802 Background: SAR, a known adverse event of cancer therapy has variable severity. Despite the availability of many approved grading tools, there is still a lack of a globally applicable grading system. To address this, World Allergy Organization
Autor:
Beulah Elsa Thomas, Mithua Ghosh, Gautam Balaram, Hrishi Varayathu, Lalram Sangi, Rashi Yogendranath Tiwari, Renjan Thomas, Sriniivas Bj, Vinayak Munirathnam, Radheshyam Naik, Suhail Sayeed Mufti, Basavalinga S. Ajaikumar, Shalaka Somayaji, Smruthy Ann Mathew, Satheesh Chiradoni Thungappa
Publikováno v:
Journal of Clinical Oncology. 39:e15020-e15020
e15020 Background: Neutrophil-Lymphocyte Ratio (NLR) and Lymphocyte-Monocyte Ratio (LMR) have been under scrutiny for their potential as a prognostic tool in various cancers. While there have been conflicting opinions on their reliability, NLR has sh